MAPT and Alzheimer disease: These markers, in particular different variants of phosphorylated tau (p-tau), exhibit high performance in identifying AD pathology in the differential diagnosis of cognitive decline and demonstrate excellent prognostic performance to predict progression to AD dementia13.